n-furfuryladenine
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
2
Earliest trial started Jun 1, 2007 (NCT00492479)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 2 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Loading structure…
SMILES
c1coc(CNc2ncnc3[nH]cnc23)c1- Mol. weight
- 215.22 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Delivery
- Parenteral
- Availability
- Prescription Only
Oral
No
Parenteral
Yes
Topical
No
Sources
- ChEMBLCHEMBL228792 ↗
- ChEMBLCHEMBL1201636 ↗
Also known as
- 2-furanmethanamine
- 6-furfuryladenine
- 6-furfuryladenine
- 6-furfuryladenine
- 6-furfuryladenine
- 6-furfurylaminopurine
- kinetin
- kinetin
- kinetin
- kinetin
- kinetin
- kinetin
- n-furfuryladenine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01898182 | Phase 4 | Nov 30, 2013 | Makati Medical Center |
| NCT02274051 | Phase 2 | Nov 1, 2009 | New York University |
| NCT00492479 | Phase 4 | Jun 1, 2007 | Innovative Medical Research of South Florida, Inc |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Innovative Medical Research of South Florida, Inc | For profit | 1 | 1 | 1 | 2007 |
| Makati Medical Center | Academic/Hospital | 1 | 1 | 1 | 2013 |
| New York University | Academic/Hospital | 1 | 1 | 1 | 2009 |
3 organizations
Page 1 / 1